𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients

✍ Scribed by Patricia Diana Sørensen…

Book ID
120908873
Publisher
Springer-Verlag
Year
2013
Tongue
English
Weight
246 KB
Volume
139
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum epidermal growth factor receptor/H
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a

Serum EGFR and serum HER-2/neu are usefu
Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy
✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t